Last reviewed · How we verify
NCT05882981
Increased Femoral Anteversion and Physical Performance
trial testing Sit and reach test in High Femoral Anteversion in 44 participants. Completed in 14 January 2024.
20 December 2023
Quick facts
| Lead sponsor | Bezmialem Vakif University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 44 |
| Start date | 20 October 2023 |
| Primary completion | 20 December 2023 |
| Estimated completion | 14 January 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Sit and reach test
- Hand grip strength measurement
- Back-leg-chest muscle strength measurement
- Functional performance
- Functional capacity
Conditions studied
- High Femoral Anteversion — all drugs for High Femoral Anteversion →
- Muscle Strength — all drugs for Muscle Strength →
- Flexibility — all drugs for Flexibility →
- Functional Performance — all drugs for Functional Performance →
Sponsor
Bezmialem Vakif University
Who can join
Adults 17 to 26, any sex, with High Femoral Anteversion or Muscle Strength. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is important to determine how high femoral anteversion, which is one of the lower extremity malalignments, affects physical performance and to what extent it affects the daily life of the individual. As far as we know, there is no study on this subject except for a study conducted by Staheli et al. in 1977. Therefore, the investigators planned to determine whether and to what extent high femoral anteversion has an effect on physical performance in healthy young adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05882981
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Bezmialem Vakif University trials
Trials by the same sponsor.
- NCT07369297 — PULP SENSIBILITY AND MASSETER INHIBITORY REFLEX IN DIABETIC POLYNEUROPATHY · not yet recruiting
- NCT07433595 — Association Between Child and Parental Stress and Bruxism in Children Aged 8-11 Years · not yet recruiting
- NCT07443111 — Comparison of Virtual Reality-Based and Routine Preoperative Education on Surgical Anxiety and Salivary Cortisol · NA · not yet recruiting
- NCT07421349 — Comparison of Pulmonary Functions and Respiratory Muscle Strength Between Children With Hearing Impairment and Healthy P · not yet recruiting
- NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05882981 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bezmialem Vakif University
- Last refreshed: 17 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05882981.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing